glp-1 allulose is a agonist GLP-1-based therapies for type 2 diabetes: from single GLP-1 Release by Rare Sugar

Topline results from the ESSENCE trial demonstrated that 62.7% of patients who received once-weekly Wegovy 2.4 mg SC had improved steatohepatitis and 37% had improved liver fibrosis compared 34.1% and 22.5%, respectively, of patients who received placebo

7ac) and those that did not (Extended Data Fig

Expression of a rice Lambda class of glutathione S-transferase, OsGSTL2, in Arabidopsis provides tolerance to heavy metal and other abiotic stresses

We approached this by identifying omics- features (i.e., expression, mutation, copy number, pathways, metabolites, etc.) that are predictive of NRF2 CRISPR knockout scores from the DepMap

They should not take an extra dose